Back to Verition Fund Management LLC Verition Fund Management LLC

NONOVOCURE LTD

Showing 6 of 17 quarters

Position history for Verition Fund Management LLCVerition Fund Management LLC's holdings in NOVOCURE LTD

No. Verition Fund Management exited its NOVOCURE position in Q4 2025. Its Q3 2025 13F listed 3,000,000 shares worth $3M. Verition Fund Management already held NOVOCURE in its Q4 2021 13F, the earliest on record, and held it in 16 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$18.5M

Total Shares Change

-19.6M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q4
Latest
Exited
0
-100.0%
$00.0%—
0
2025-Q3
Unchanged
3M
0.0%
$3M0.0%—
0
2025-Q2
Increased
3M
+999x
$2.9M0.0%—
42
2025-Q1
Decreased
3,000
-99.9%
$2.9M0.0%—
0
2024-Q4
Decreased
3M
-84.7%
$2.9M0.0%—
0
2024-Q3
Unchanged
19.6M
0.0%
$18.5M0.1%—
0

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used